Sex and gender influences on pharmacological response: an overview
The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Research on the specific effects of sex and gender on pharmacokinetics and pharmacodynamics, as well as safety profile tolerability and drug efficacy, of medications remain meager because female animals and women have only recently been included in the pharmacological domain. To date, the influence of sex and gender on access to care and emotional factors, including patients and care provider dyads, the placebo effect, adherence, and safety profiles, are discussed. Furthermore, differences in drug responses, mainly for antidiabetic drugs, have been described. However, further studies are needed to explore the impact of sex and gender on reaching the most appropriate and tailored prescription for each patient, regardless of sex and gender.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Constructions of masculinity and their influence on men's well-being: a theory of gender and health
Courtenay, W. H. (2000) · Social Science & Medicine · doi:10.1016/s0277-9536(99)00390-1 · Cited by 4,091 · cited 1×
“Women and men diverge in their health behaviors and beliefs [106–108], and they also have different behaviors toward drugs [100,109–111].”
BackgroundGlycemic durability of rosiglitazone, metformin, or glyburide monotherapy
Kahn, S. E., Haffner, S. M., Heise, M. A., Herman, W. H., Holman, R. R., Jones, N. P., Kravitz, B. G., Lachin, J. M., O'Neill, M. C., Zinman, B., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa066224 · Cited by 2,962
Davis, K. (2008) · Feminist Theory · doi:10.1177/1464700108086364 · Cited by 2,539
Petty, R. E., Wegener, D. T., & Fabrigar, L. R. (1997) · Annual Review of Psychology · doi:10.1146/annurev.psych.48.1.609 · Cited by 2,290
DiMatteo, M. R. (2004) · Medical Care · doi:10.1097/01.mlr.0000114908.90348.f9 · Cited by 2,169 · cited 1×
“In other cases, a sexual dimorphism in adherence was not detected [118,163,165].”
BackgroundMosca, L., Benjamin, E. J., Berra, K., Bezanson, J. L., Dolor, R. J., Lloyd-Jones, D. M., Newby, L. K., Piña, I. L., Roger, V. L., Shaw, L. J., et al. (2011) · Circulation · doi:10.1161/cir.0b013e31820faaf8 · Cited by 2,143
Medication Adherence: WHO Cares?
Brown, M. T., & Bussell, J. K. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0575 · Cited by 1,928 · cited 1×
“(Hippocrates, Decorum quoted in [94]).”
Basal insulin and cardiovascular and other outcomes in dysglycemia
The ORIGIN Trial Investigators (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1203858 · Cited by 1,636 · cited 1×
“However, it is still unclear whether glargine, a recombinant DNA analog of human insulin that displays increased affinity for the insulin and insulin-like growth factor-1 receptors [228], increases the risk of malignancy [229–233].”
AMP-activated protein kinase induces a p53-dependent metabolic checkpoint
Jones, R. G., Plas, D. R., Kubek, S., Buzzai, M., Mu, J., Xu, Y., Birnbaum, M. J., & Thompson, C. B. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.03.027 · Cited by 1,619
Frezza, M., di Padova, C., Pozzato, G., Terpin, M., Baraona, E., & Lieber, C. S. (1990) · New England Journal of Medicine · doi:10.1056/nejm199001113220205 · Cited by 1,328
Sex Differences in Pharmacokinetics and Pharmacodynamics
Soldin, O. P., & Mattison, D. R. (2009) · Clinical Pharmacokinetics · doi:10.2165/00003088-200948030-00001 · Cited by 1,163 · cited 5×
“Excipients & sex-gender Pharmacokinetics are highly influenced by sex-gender ([20,22,23,39–41] and quoted literature).”
BackgroundInfluentialA Comprehensive Review of the Placebo Effect: Recent Advances and Current Thought
Price, D. D., Finniss, D. G., & Benedetti, F. (2008) · Annual Review of Psychology · doi:10.1146/annurev.psych.59.113006.095941 · Cited by 1,146
Sex/Gender Differences in Cardiovascular Disease Prevention: What a Difference a Decade Makes
Mosca, L., Barrett-Connor, E., & Kass Wenger, N. (2011) · Circulation · doi:10.1161/circulationaha.110.968792 · Cited by 1,045 · cited 1×
“Racial and sex-gender disparities in cardiovascular outcomes have been well described [125–127].”
BackgroundBowker, S. L., Majumdar, S. R., Veugelers, P., & Johnson, J. A. (2006) · Diabetes Care · doi:10.2337/diacare.29.02.06.dc05-1558 · Cited by 933
A comparison of glyburide and insulin in women with gestational diabetes mellitus
Langer, O., Conway, D. L., Berkus, M. D., Xenakis, E. M.-J., & Gonzales, O. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010193431601 · Cited by 924 · cited 1×
“Only one sulfonylurea, glibenclamide, can be safely used during pregnancy, and it represents an alternative to insulin for the treatment of gestational diabetes [267].”
BackgroundResisting medicines: a synthesis of qualitative studies of medicine taking
Pound, P., Britten, N., Morgan, M., Yardley, L., Pope, C., Daker-White, G., & Campbell, R. (2005) · Social Science & Medicine · doi:10.1016/j.socscimed.2004.11.063 · Cited by 868 · cited 2×
“Women and men diverge in their health behaviors and beliefs [106–108], and they also have different behaviors toward drugs [100,109–111].”
BackgroundAMP-Activated Protein Kinase – Development of the Energy Sensor Concept
Hardie, D. G., Hawley, S. A., & Scott, J. W. (2006) · The Journal of Physiology · doi:10.1113/jphysiol.2006.108944 · Cited by 813
Women’s health, men’s health, and gender and health: implications of intersectionality
Hankivsky, O. (2012) · Social Science & Medicine · doi:10.1016/j.socscimed.2011.11.029 · Cited by 796 · cited 1×
“Considering that gender is embedded in social and economic factors, it is not difficult to hypothesize that sex-gender may play a role in adherence [105].”
BackgroundPatient non-compliance: Deviance or reasoned decision-making?
Donovan, J. L., & Blake, D. R. (1992) · Social Science & Medicine · doi:10.1016/0277-9536(92)90206-6 · Cited by 785
Mazzaglia, G., Ambrosioni, E., Alacqua, M., Filippi, A., Sessa, E., Immordino, V., Borghi, C., Brignoli, O., Caputi, A. P., Cricelli, C., et al. (2009) · Circulation · doi:10.1161/circulationaha.108.830299 · Cited by 637 · cited 1×
“Furthermore, after acute coronary syndrome, myocardial infarction and hypertension, adherence was lower in women than in men [60,132–139].”
BackgroundRisk of Bladder Cancer Among Diabetic Patients Treated With Pioglitazone
Lewis, J. D., Ferrara, A., Peng, T., Hedderson, M., Bilker, W. B., Quesenberry, C. P., Vaughn, D. J., Nessel, L., Selby, J., & Strom, B. L. (2011) · Diabetes Care · doi:10.2337/dc10-1068 · Cited by 625
Cancer risk in diabetic patients treated with metformin: a systematic review and meta-analysis
Noto, H., Goto, A., Tsujimoto, T., & Noda, M. (2012) · PLoS ONE · doi:10.1371/journal.pone.0033411 · Cited by 566 · cited 1×
“Metformin improves the prognosis of breast cancer, raising the possibility of its use as an adjuvant treatment for breast cancer [242–245].”
BackgroundTrends in smoking behaviour between 1985 and 2000 in nine European countries by education
Giskes, K., Kunst, A. E., Benach, J., Borrell, C., Costa, G., Dahl, E., Dalstra, J. A. A., Federico, B., Helmert, U., Judge, K., et al. (2005) · Journal of Epidemiology and Community Health · doi:10.1136/jech.2004.025684 · Cited by 472 · cited 1×
“For example, subjects with a lower socioeconomic and educational status smoke more than individuals with a higher socioeconomic status [33], and smoking status is associated with mortality in humans, as it increases the risk of developing numerous diseases [34].”
BackgroundThe Bare Bones of Sex: Part 1—Sex and Gender
Fausto‐Sterling, A. (2005) · Signs: Journal of Women in Culture and Society · doi:10.1086/424932 · Cited by 437 · cited 1×
“Therefore, it appears more appropriate to speak of the ‘sex/gender system’ [9,10] to describe ‘a set of arrangements by which the biological”
BackgroundSex Differences in Patients?? and Physicians?? Communication During Primary Care Medical Visits
Drph, D. R., Lipkin, M., & Korsgaard, A. (1991) · Medical Care · doi:10.1097/00005650-199111000-00002 · Cited by 414 · cited 1×
“Additionally, female and male physicians communicate differently with their patients; female doctors discuss more lifestyle and social issues with their patients, giving medical information during a visit [170,171] and adopting a participatory decision-making style [172].”
BackgroundSex differences in anxiety and emotional behavior
Donner, N. C., & Lowry, C. A. (2013) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-013-1271-7 · Cited by 379 · cited 1×
“Notably, anxiety disorders and mood disturbances are higher in women than in men [85].”
BackgroundThiazolidinediones and the risk of lung, prostate, and colon cancer in patients with diabetes
Govindarajan, R., Ratnasinghe, L., Simmons, D. L., Siegel, E. R., Midathada, M. V., Kim, L., Kim, P. J., Owens, R. J., & Lang, N. P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.07.2777 · Cited by 336 · cited 1×
“Conversely, diabetics treated with thiazolidinediones have a reduced risk of cancer [280,281].”
BackgroundPaulson, P. E., Minoshima, S., Morrow, T. J., & Casey, K. L. (1998) · Pain · doi:10.1016/s0304-3959(98)00048-7 · Cited by 325 · cited 1×
“Notably, a positron emission tomography study reported that females exposed to a placebo show significantly greater activation of the contralateral prefrontal cortex compared with males [82].”
BackgroundChronic Stress Modulates the Immune Response to a Pneumococcal Pneumonia Vaccine
Glaser, R., Sheridan, J., Malarkey, W. B., MacCallum, R. C., & Kiecolt-Glaser, J. K. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200011000-00010 · Cited by 295 · cited 1×
“Some sex-gender differences in drug response depend on social factors [44,45], which are related to the stress response that is sexual dimorphic [46] being also involved in the response to xenobiotics, including drugs [47].”
BackgroundGender and racial disparities in adherence to statin therapy: A meta-analysis
Lewey, J., Shrank, W. H., Bowry, A. D. K., Kilabuk, E., Brennan, T. A., & Choudhry, N. K. (2013) · American Heart Journal · doi:10.1016/j.ahj.2013.02.011 · Cited by 267 · cited 1×
“Interestingly, a recent meta-analysis indicates that among patients, which use statins, women and non-white patients are at increased risk for non-adherence [126].”
BackgroundMetformin and Other Biguanides in Oncology: Advancing the Research Agenda
Pollak, M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-10-0175 · Cited by 240 · cited 1×
“Furthermore, the anticancer activity of metformin could be associated with a decrease in insulin resistance and the inhibition of IGF-1R/IR, Akt, ERK and mTOR phosphorylation [243].”
BackgroundElovainio, M., Ferrie, J. E., Singh-Manoux, A., Shipley, M., Batty, G. D., Head, J., Hamer, M., Jokela, M., Virtanen, M., Brunner, E., et al. (2011) · American Journal of Epidemiology · doi:10.1093/aje/kwr149 · Cited by 131
Cancer risks in thiazolidinedione users compared to other anti-diabetic agents
Koro, C., Barrett, S., & Qizilbash, N. (2007) · Pharmacoepidemiology and Drug Safety · doi:10.1002/pds.1352 · Cited by 107 · cited 1×
“Conversely, diabetics treated with thiazolidinediones have a reduced risk of cancer [280,281].”
BackgroundNahon, S., Lahmek, P., Saas, C., Durance, C., Olympie, A., Lesgourgues, B., & Gendre, J.-P. (2011) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21482 · Cited by 102
Enhancing Drug Compliance in Lipid-Lowering Treatment
LaRosa, J. H. (2000) · Archives of Family Medicine · doi:10.1001/archfami.9.10.1169 · Cited by 77 · cited 1×
“Nevertheless, adherence to a prescribed regimen plays a mandatory role in reaching therapeutic efficacy [95–99], and approximately 50% of patients with chronic illness do not take their medications as prescribed [100,101].”
BackgroundMenstrual Cycle Effects on Insulin Sensitivity in Women with Type 1 Diabetes: A Pilot Study
Trout, K. K., Rickels, M. R., Schutta, M. H., Petrova, M., Freeman, E. W., Tkacs, N. C., & Teff, K. L. (2007) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2006.0004 · Cited by 75 · cited 2×
“For example, fertile women in the second half of their menstrual cycle require a higher insulin dosage to maintain metabolic control [223].”
BackgroundSeghieri, G., Anichini, Cosimi, S., Carlo, D., Bellis, D., Franconi, Orsini, P., & Baccetti (2013) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s42729 · Cited by 63 · cited 3×
“A recent paper reporting a real-life experience with the agonist exatinide revealed that a high proportion of males and females reach glycemic target and weight loss, respectively [282].”
BackgroundInfluentialPsychophysiological stress: a significant parameter in drug pharmacokinetics
Konstandi, M. (2013) · Expert Opinion on Drug Metabolism & Toxicology · doi:10.1517/17425255.2013.816283 · Cited by 31 · cited 1×
“Emotional stressors can change the activity of the cytochrome P450s (CYP), and the variation appears to be linked to glucocorticoids and epinephrine/norepinephrine [93].”
Background
Cited by
Gender in cardiovascular diseases: impact on clinical manifestations, management, and outcomes
(2016) · European Heart Journal · doi:10.1093/eurheartj/ehv598 · Cited by 739
Reporting Sex, Gender, or Both in Clinical Research?
Clayton, J. A., & Tannenbaum, C. (2016) · JAMA · doi:10.1001/jama.2016.16405 · Cited by 537
Sex differences in substance use disorders: focus on side effects
Agabio, R., Campesi, I., Pisanu, C., Gessa, G. L., & Franconi, F. (2016) · Addiction Biology · doi:10.1111/adb.12395 · Cited by 117
Self-citationThe female side of pharmacotherapy for ADHD—A systematic literature review
Kok, F. M., Groen, Y., Fuermaier, A. B. M., & Tucha, O. (2020) · PLOS ONE · doi:10.1371/journal.pone.0239257 · Cited by 86
“Although studies specifically focusing on sex differences in efficacy or effectiveness of ADHD pharmacotherapy are scarce, recent studies show females may respond differently than males [58,59].”
BackgroundSex/gender differences in cognitive abilities
Kheloui, S., Jacmin-Park, S., Larocque, O., Kerr, P., Rossi, M., Cartier, L., & Juster, R.-P. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105333 · Cited by 78
Metadata
- Authors
- Franconi, F., & Campesi, I.
- Venue
- Expert Review of Clinical Pharmacology
- Publisher
- Informa UK Limited
- Published
- 2014-05-24
- Volume
- 7
- Issue
- 4
- Pages
- 469-485
- ISSN
- 1751-2433 (ISSN-L)
- 1751-2441
- OpenAlex
- W2143291772
- Cited by
- 132
- References
- 38
- FWCI
- 7.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.